Little Things Matter: A Time and Motion Study of Pharmacists' Activities in a Paediatric Hospital

Elin C Lehnbom1, Ling Li2, Mirela Prgomet2

  • 1Faculty of Pharmacy, University of Sydney, Sydney.

Insights

This study observed clinical pharmacists in a pediatric hospital, finding medication review was their primary task. This research provides crucial data on pediatric pharmacist workflow and time allocation.

Area of Science:

  • Pharmacy Practice
  • Pediatric Healthcare
  • Health Services Research

Background:

  • Healthcare provider time distribution impacts care quality and safety, extensively studied in adult settings.
  • Paediatric healthcare provider workflows remain largely unquantified, despite unique patient needs.

Purpose of the Study:

  • To quantify the time allocation of clinical pharmacists in a paediatric hospital setting.
  • To establish a baseline for evaluating workflow impacts of future healthcare innovations.

Main Methods:

  • A direct observational time and motion study was employed.
  • Two independent observers shadowed seven clinical pharmacists across eight wards for over 60 hours.

Main Results:

  • Clinical pharmacists spent the majority of their time on medication review (32.6%).
  • Other key activities included communication, non-clinical tasks, supply, medication discussion, and transit.
  • Pharmacists experienced frequent interruptions (3.5 per hour) and engaged in multitasking (4.4% of observed time).

Conclusions:

  • This is the first study to quantify paediatric clinical pharmacist time distribution.
  • The findings offer essential baseline data for assessing the impact of interventions like electronic medication management systems on workflow.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
313
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
423
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
645
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
360
Chronopharmacokinetics: Time-Dependent Pharmacokinetics01:20

Chronopharmacokinetics: Time-Dependent Pharmacokinetics

Chronopharmacokinetics studies the temporal change in drug absorption and elimination. These changes can be cyclical or non-cyclical. Cyclical changes occur over a regular interval, while non-cyclical changes occur over a longer, irregular period.
Time-dependent pharmacokinetics refers to non-cyclical changes in drug rate processes over a period of time. It can lead to nonlinear pharmacokinetics, where the relationship between drug concentration and time is not proportional. Non-cyclical...
482
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
440